- Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

ADC Therapeutics initiates dosing in solid tumour trial

The trial plans to identify an appropriate dosing regimen for Cami plus pembrolizumab. Credit: National Cancer Institute on Unsplash.